5 potential pitfalls to avoid for successful vaccine trials

John Holtzclaw, scientific advisor at Eurofins Viracor Biopharma, outlines five potential pitfalls in vaccine clinical trials—study timelines, test system suitability, study design and endpoint analysis, sample integrity, and regulatory compliance. He discusses how to mitigate each challenge, emphasizing adapting to evolving regulations and addressing local considerations, especially for global trials. Download the free handout for further detail.